Quadria Capital completed the investment in NephroPlus for $103m.

Quadria Capital, a healthcare-focused private equity firm, completed the investment in NephroPlus, a dialysis network, for $103m. “Quadria’s investment in NephroPlus underscores our ambition to invest in regional champions of Asian healthcare, who are providing high-quality, affordable healthcare to large, under-served populations. NephroPlus has demonstrated its ability to significantly improve health outcomes for its patients, whilst maintaining industry-leading growth and profitability. We look forward to working with their leadership team to continue to expand their footprint, increase access to dialysis services across Asia and accelerate the next phase of growth for NephroPlus," Sunil Thakur, Quadria Capital Partner and Head of South Asia.